As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.

The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These ...

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...

Americans have struggled to afford the blockbuster class of weight-loss medications called GLP-1, or glucagon-like peptide-1, ...

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, ...

The popular glucagon-like peptide-1 (GLP-1) receptor agonists known to help in weight loss as well as manage blood sugar can ...

Drug manufacturers are racing to develop an oral version of popular weight loss injectables like Ozempic, and early studies ...

A registered dietitian shares the best diet and exercise tips to help optimize your GLP-1 response for faster weight loss.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...